IND-SWIFT
Ind-Swift Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in IND-SWIFT
Start SIPInd-Swift Share Price
Ind-Swift Investment Rating
-
Master Rating:
-
Ind-Swift has an operating revenue of Rs. 394.48 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of -5% needs improvement, NULL The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 1 which is a POOR score indicating inconsistency in earnings, a RS Rating of 21 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of A is the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 104 | 95 | 106 | 104 | 97 | 90 | 94 |
| Operating Expenses Qtr Cr | 93 | 90 | 96 | 92 | 85 | 80 | 95 |
| Operating Profit Qtr Cr | 11 | 5 | 10 | 12 | 13 | 11 | 0 |
| Depreciation Qtr Cr | 7 | 7 | 8 | 8 | 8 | 8 | 8 |
| Interest Qtr Cr | 15 | 15 | 14 | 14 | 15 | 12 | 10 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | -11 | -15 | -5 | -6 | -5 | -4 | -17 |
Ind-Swift Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- 9.21
- 50 Day
- 9.32
- 100 Day
- 9.64
- 200 Day
- 9.98
- 20 Day
- 9.21
- 50 Day
- 9.25
- 100 Day
- 9.55
- 200 Day
- 10.44
Ind-Swift Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 9.44 |
| Second Resistance | 9.62 |
| Third Resistance | 9.79 |
| RSI | 50.63 |
| MFI | 82.69 |
| MACD Single Line | -0.04 |
| MACD | -0.02 |
| Support | |
|---|---|
| First Resistance | 9.09 |
| Second Resistance | 8.92 |
| Third Resistance | 8.74 |
Ind-Swift Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 34,746 | 3,000,665 | 86.36 |
| Week | 37,748 | 2,846,984 | 75.42 |
| 1 Month | 74,934 | 4,818,975 | 64.31 |
| 6 Month | 58,189 | 3,576,267 | 61.46 |
Ind-Swift Result Highlights
Ind-Swift Synopsis
NSE-Medical-Diversified
Ind-Swift L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 397.71 Cr. and Equity Capital is Rs. 10.83 Cr. for the Year ended 31/03/2022. Ind-Swift Ltd. is a Public Limited Listed company incorporated on 06/06/1986 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24230CH1986PLC006897 and registration number is 006897.| Market Cap | 50 |
| Sales | 408 |
| Shares in Float | 2.38 |
| No of funds | 4 |
| Yield |
| Book Value | -0.04 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | |
| Alpha | -0.08 |
| Beta | 0.6 |
Ind-Swift
| Owner Name | Sep-22 | Jun-22 | Mar-22 | Dec-21 |
|---|---|---|---|---|
| Promoters | 55.58% | 55.58% | 55.58% | |
| Mutual Funds | ||||
| Foreign Portfolio Investors | ||||
| Financial Institutions/ Banks | ||||
| Individual Investors | 30.4% | 30.24% | 30.61% | |
| Others | 14.02% | 14.18% | 13.81% |
Ind-Swift Management
| Name | Designation |
|---|---|
| Mr. S R Mehta | Executive Chairman |
| Mr. N R Munjal | Non Executive Director |
| Dr. Gopal Munjal | Managing Director & CEO |
| Dr. V R Mehta | Joint Managing Director |
| Mr. Himanshu Jain | Non Executive Director |
| Mr. Rishav Mehta | Non Executive Director |
| Mr. S P Sharma | Independent Director |
| Dr. V K Arora | Independent Director |
| Mr. S C Galhotra | Independent Director |
| Dr. Jatender Kumar Kakkar | Independent Director |
| Ms. Anoop Michra | Independent Director |
| Mr. Jagvir Singh Ahluwalia | Independent Director |
Ind-Swift Forecast
Price Estimates
Ind-Swift Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2022-11-14 | Quarterly Results | |
| 2022-08-09 | Quarterly Results | |
| 2022-05-30 | Audited Results | |
| 2022-02-14 | Quarterly Results | |
| 2021-11-13 | Quarterly Results |
Ind-Swift FAQs
What is Share Price of Ind-Swift ?
Ind-Swift share price is ₹9 As on 04 December, 2022 | 15:01
What is the Market Cap of Ind-Swift ?
The Market Cap of Ind-Swift is ₹50.9 Cr As on 04 December, 2022 | 15:01
What is the P/E ratio of Ind-Swift ?
The P/E ratio of Ind-Swift is -1.4 As on 04 December, 2022 | 15:01
What is the PB ratio of Ind-Swift ?
The PB ratio of Ind-Swift is -0.1 As on 04 December, 2022 | 15:01